Formulation Strategies for Sustained Release of Proteins

• World Health Organisation. Adherence to Long-term Therapies – Evidence for Action. ISBN: 9241545992 (2003).
   Google Scholar
• Folkman J , LongDM. The use of silicone rubber as a carrier for prolonged drug therapy. Surg. Res.4, 139–142 (1964).
   PubMed Web of Science ®Google Scholar
• Heller J . Patient-friendly bioerodible drug delivery systems. J. Control. Release133, 88–89 (2009).
   PubMed Web of Science ®Google Scholar
• Kosobucki BR , FreemanWR, ChengL. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye. Br. J. Ophthalmol.90, 705–708 (2006).
   PubMed Web of Science ®Google Scholar
• Govardhan C , KhalafN, JungCWet al. Novel long acting crystal formulation of human growth hormone. Pharm. Res. 22(9), 1461–1470 (2005).
   PubMed Web of Science ®Google Scholar
• Kim SJ , HahnSK, KimMJet al. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles. J. Control. Release 104, 323–335 (2005).
   PubMed Web of Science ®Google Scholar
• Hahn SK , KimSJ, KimMJ, KimDH. Characterisation and in vivo study of sustained release formulation of human growth hormone using sodium hyaluronate. Pharm. Res.21(8), 1374–1381 (2004).
   PubMed Web of Science ®Google Scholar
• Bidlingmaier M , KimJ, SavoyCet al. Comparative pharmacokinetics and pharmacodynamics of a new sustained release growth hormone, LB03002, versus daily GH in adults with GH deficiency. J. Clin. Endo. Met. 91(8), 2926–2930 (2006).
   PubMed Web of Science ®Google Scholar
• Peter F , SavoyC, JiHJet al. Pharmacokinetic and pharmacodynamic profile of a new sustained release GH formulation, LB03002, in children with GH deficiency. Eur. J. Endo. 160, 349–355 (2009).
   PubMed Web of Science ®Google Scholar
• Chang TMS . Semipermeable microcapsules. Science146 (3643), 524–525 (1964).
   PubMed Web of Science ®Google Scholar
• Chang TMS , PoznanskyMJ. Semipermeable microcapsules containing catalase for enzyme replacement in acatalasaemic mice. Nature218, 243–245 (1968).
   PubMed Web of Science ®Google Scholar
• Folkman J , LangerR. Polymers for the sustained release of proteins and other macromolecules. Nature263, 797–800 (1976).
   PubMed Web of Science ®Google Scholar
• Anderson JM , ShiveMS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev.28, 5–24 (1997).
   PubMed Web of Science ®Google Scholar
• Blasi P , D‘SouzaSS, SelminF, DeLucaPP. Plasticizing effect of water on poly(lactide-co-glycolide). J. Control. Release108, 1–9 (2005).
   PubMed Web of Science ®Google Scholar
• Tracey MA , WardKL, FirouzabadianLet al. Factors affecting the degradation rate of PLGA microspheres in vivo and in vitro. Biomaterials 20, 1057–1062 (1999).
   PubMed Web of Science ®Google Scholar
• Passerini N , CraigDQM. An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated DSC. J. Control. Release73, 111–115 (2001).
   PubMed Web of Science ®Google Scholar
• Wang J , WangBM, ShwendemanSP. Characterisation of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres. J. Control. Release82, 289–307 (2002).
   PubMed Web of Science ®Google Scholar
• Fu K , PackDW, KlibanovAM, LangerR. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res.17(1), 100–106 (2000).
   PubMed Web of Science ®Google Scholar
• Ding AG , SchwendemanSP. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy. Pharm. Res.25(9), 2041–2052 (2008).
   PubMed Web of Science ®Google Scholar
• Li L , SchwendemanSP. Mapping microclimate pH in PLGA microspheres. J. Control. Release101, 163–173 (2005).
   PubMed Web of Science ®Google Scholar
• Ding AG , ShenderovaA, SchwendemanSP. Prediction of microclimate pH in poly(lactic-co-glycolic acid) films. J. Am. Chem. Soc.128, 5384–5390 (2006).
   PubMed Web of Science ®Google Scholar
• Klose D , SiepmannF, ElkharrazK, SiepmannJ. PLGA-based drug delivery systems – importance of the type of drug and device geometry. Int. J. Pharm.354(1–2), 95–103 (2008).
   PubMed Web of Science ®Google Scholar
• Miller RA , BradyJM, CutrightDE. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res.11, 711–719 (1977).
   PubMed Web of Science ®Google Scholar
• Dunne M , CorriganOI, RamtoolaZ. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glucolide particles. Biomaterials21, 1659–1668 (2000).
   PubMed Web of Science ®Google Scholar
• Perez-Marrero R , TylerRC. A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer. Expert Opin. Pharmacother.5(2), 447–457 (2004).
   PubMed Web of Science ®Google Scholar
• Brodbeck KJ , PushpalaS, McHughAJ. Sustained release of human growth hormone from PLGA solution depots. Pharm. Res.16(12), 1825–1829 (1999).
   PubMed Web of Science ®Google Scholar
• Shah NH , RailkarAS, ChenFCet al. A biodegradable injectable implant for delivering micro and macromolecules using PLGA copolymers. J. Control. Release 27, 391–147 (1993).
   Web of Science ®Google Scholar
• Graham PD , BrodbeckKJ, McHughAJ. Phase inversion dynamics of PLGA solutions related to drug delivery. J. Control. Release58, 233–245 (1999).
   PubMed Web of Science ®Google Scholar
• Brodbeck KJ , DesNoyerJR, McHughAJ. Phase inversion dynamics of PLGA solutions related to drug delivery – Part II the role f solution thermodynamics and batch-side mass transfer. J. Control. Release62, 333–344 (1999).
   PubMed Web of Science ®Google Scholar
• Dunn RL , TiptonAJ, MenardiEM. A biodegradable in-situ forming drug delivery system. Proc. Intern. Symp. Control. Release Bioact. Mater.18, 456–466 (1991).
   Google Scholar
• Schoenhammer K , PetersenH, GuethleinF, GoepferichA. Injectable in situ forming depot systems: PEG-DAE as a novel solvent for improved PLGA storage stability. Int. J. Pharm.371, 33–39 (2009).
   PubMedGoogle Scholar
• Schoenhammer K , PetersenH, GuethleinF, GoepferichA. Poly(ethylene glycol)500 dimethylether as a novel solvent for injectable in situ forming depots. Pharm. Res.26(12), 2568–2577 (2009).
   PubMed Web of Science ®Google Scholar
• Shively ML , CoontsBA, RennerWD, SouthardSL, BennettAT. Physicochemical characterisation of a polymeric injectable implant delivery system. J. Control. Release33, 237–243 (1995).
   Web of Science ®Google Scholar
• Astaneh R , ErfanM, MoghimiH, MobediH. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behaviour. J. Pharm. Sci.98(1), 135–145 (2009).
   PubMed Web of Science ®Google Scholar
• Astaneh R , Nafissi-VarchehN, ErfanM. Zinc–leuprolide complex: preparation, physicochemical characterisation and release behaviour from in situ forming implant. J. Peptide Sci.13, 649–654 (2007).
   PubMed Web of Science ®Google Scholar
• Ravivarapu HB , MoyerKL, DunnRL. Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. Int. J. Pharm.194, 181–191 (2000).
   PubMed Web of Science ®Google Scholar
• Jain RA , RhodesCT, RailkarAMet al. Controlled release of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. Pharm. Sci. 1(Suppl. 1), S298 (1998).
   Google Scholar
• Luan X , BodmeierR. Influence of the PLGA type on the leuprolide release from in situ forming microparticle systems. J. Control. Release110, 266–272 (2006).
   PubMed Web of Science ®Google Scholar
• Luan X , BodmeierR. In situ forming microparticle system for drug delivery of leuprolide acetate: influence of the formulation and processing parameters. Eur. J. Pharm. Sci.27, 143–149 (2006).
   PubMed Web of Science ®Google Scholar
• Kranz H , BodmeierR. A novel in situ forming drug delivery system for controlled parenteral drug delivery. Int. J. Pharm.332, 107–114 (2007).
   PubMed Web of Science ®Google Scholar
• Okumu F , DaoLN, FielderPJet al. Sustained delivery of human growth hormone from a novel gel system: SABER™. Biomaterials 23, 4353–4358 (2002).
   PubMed Web of Science ®Google Scholar
• Pechenov S , ShenoyB, YangMX, BasuSK, MargolinAL. Injectable controlled release formulations incorporating protein crystals. J. Control. Release96, 149–158 (2004).
   PubMed Web of Science ®Google Scholar
• Tae G , KornfieldJA, HubbellJA. Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol). Biomaterials26, 5259–5266 (2005).
   PubMed Web of Science ®Google Scholar
• Ruiz-Hornillos J , Henriquez-SantanaA, Moreno-FernandezAet al. Systemic allergic dermatitis caused by the solvent of Eligard. Contact Dermatitis 61(6), 355–356 (2009).
   PubMed Web of Science ®Google Scholar
• Jeong B , BaeYH, LeeDS, KimSW. Biodegradable block co-polymers as injectable drug delivery systems. Nature388, 860–862 (1997).
   PubMed Web of Science ®Google Scholar
• Zentner GM , RathiR, ShihCet al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Release 72, 203–215 (2001).
   PubMed Web of Science ®Google Scholar
• Chen S , SinghJ. Controlled release of growth hormone from thermosensitive triblock copolymer systems: in vitro and in vivo evaluation. Int. J. Pharm.352, 58–65 (2008).
   PubMed Web of Science ®Google Scholar
• Katakam M , RavisWR, BangaAK. Controlled release of human growth hormone in rats following parenteral administration of poloxamers gels. J. Control. Release49, 21–26 (1997).
   Web of Science ®Google Scholar
• Katakam M , RavisWR, GoldenDL, BangaAK. Controlled release of human growth hormone following subcutaneous administration in dogs. Int. J. Pharm.152, 53–58 (1997).
   Web of Science ®Google Scholar
• Chen PC , ParkYJ, ChangLCet al. Injectable microparticle-gel system for prolonged and localised lidocaine release. I. In vitro characterization. J. Biomed. Mater. Res. 70(3), 412–419. (2004).
   Google Scholar
• Chen PC , KohaneDS, ParkYJet al. Injectable microparticle-gel system for prolonged and localised lidocaine release. II. In vivo anesthetic effects. J. Biomed. Mater. Res. 70A, 459–466 (2004).
   Web of Science ®Google Scholar
• Ricci EJ , BentleyMVLB, FarahM, BretasRES, MarchettisJM. Rheological characterisation of poloxamers 407 lidocaine hydrochloride gels. Eur. J. Pharm. Sci.17, 161–167 (2002).
   PubMed Web of Science ®Google Scholar
• Ricci EJ , LunardiLO, NanclaresDMA, MarchettiJM. Sustained release of lidocaine from poloxamers gels. Int. J. Pharm.288, 235–244 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang L , ParsonsDL, NavarreC, KompellaUB. Development and in vitro evaluation of sustained release poloxamers 407 gel formulations of ceftiofur. J. Control. Release85, 73–81 (2002).
   PubMed Web of Science ®Google Scholar
• Johnston TP , PunjabiMA, FroelichCJ. Sustained delivery of interleukin-2 from a poloxamers 407 gel matrix following intraperitoneal injection in mice. Pharm. Res.9(3), 425–434 (1992).
   PubMed Web of Science ®Google Scholar
• Katakam M , BangaAK. Use of poloxamers polymers to stabilise recombinant human growth hormone against various processing stresses. Pharm. Dev. Tech.2(2), 143–149 (1997).
   PubMedGoogle Scholar
• Jiang Z , YouY, DengXM, HaoJY. Injectable hydrogels of poly(ε-caprolactone-co-glycolide)-co-poly(ethylene glycol)-poly(ε-caprolactone-co-glycolide) triblock copolymer aqueous solutions. Polymer48, 4786–4792 (2007).
   Web of Science ®Google Scholar
• Van de Weert M , HenninkWE, JiskootW. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res.17(10), 1159–1167 (2000).
   PubMed Web of Science ®Google Scholar
• Jiang Z , HaoJ, YouY, QunG, CaoW, DengX. Biodegradable thermogelling hydrogel of P(CL-GL)-PEG-P(CL-GL) triblock copolymer: degradation and drug release behaviour. J. Pharm. Sci.98(8) 2603–2610 (2009).
   PubMed Web of Science ®Google Scholar
• Jain RA . The manufacturing technologies of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials21, 2475–2490 (2000).
   PubMed Web of Science ®Google Scholar
• Freitas S , MerkleHP, GanderB. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J. Control. Release102, 313–332 (2005).
   PubMed Web of Science ®Google Scholar
• O‘Donnell PB , McGintyJW. Preparation of microspheres by the solvent evaporation technique. Adv. Drug Delivery Rev.28, 25–42 (1997).
   PubMed Web of Science ®Google Scholar
• Sukumar M , StormsSM, De Felippis MR. Non-native intermediate conformational states of human growth hormone in the presence of organic solvents. Pharm. Res.22(5), 789–796 (2005).
   PubMed Web of Science ®Google Scholar
• Sah H . Protein behaviour at the water/methylene chloride interface. J Pharm. Sci., 88(12), 1320–1325 (1999).
   PubMed Web of Science ®Google Scholar
• Cleland JL , JonesAJS. Stable formulations of recombinant human growth hormone and interferon- γ for microencapsulation in biodegradable microspheres. Pharm. Res.13(10), 1464–1475 (1996).
   PubMed Web of Science ®Google Scholar
• Castellanos IJ , CruzG, CrespoR, GreibenowK. Encapsulation induced aggregation and loss in activity of γ-chymotrypsin and their prevention. J. Control. Release81, 307–319 (2002).
   PubMed Web of Science ®Google Scholar
• Kim HK , ParkTG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotech. Bioeng.65(6) 659–667 (1999).
   PubMed Web of Science ®Google Scholar
• Perez C , GriebenowK. Effects of salts on lysozyme stability at the water-oil interface and upon encapsulation in PLGA microspheres. Biotech. Bioeng.82(7) 825–832 (2003).
   PubMed Web of Science ®Google Scholar
• Perez C , GriebenowK. Improved activity and stability of lysozyme at the water/CH2Cl2 interface: enzyme unfolding and aggregation and its prevention by polyols. J. Pharm. Pharmacol.53, 1217–1226 (2001).
   PubMed Web of Science ®Google Scholar
• Van de Weert M , HoechstetterJ, HenninkWE, CrommelinDJA. The effect of a water/organic solvent interface on the structural stability of lysozyme. J. Control. Release68, 351–359 (2000).
   PubMed Web of Science ®Google Scholar
• Carrasquillo KG , CarroJCA, AlejandroA, ToroDD, GreibenowK. Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation. J. Pharm. Pharmacol.53, 115–120 (2001).
   PubMed Web of Science ®Google Scholar
• Pérez C , De Jesus P, Griebenow K. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method. Int. J. Pharm.248, 193–206 (2002).
   PubMedGoogle Scholar
• Cleland JL , MacA, BoydBet al. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) PLGA microspheres. Pharm. Res. 14(4) 420–425 (1997).
   PubMed Web of Science ®Google Scholar
• Cleland JL , DuenasE, DaughertyAet al. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Control. Release 49, 193–205 (1997).
   Web of Science ®Google Scholar
• Cleland JL , JohnsonO, PutneyS, JonesAJS. Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development. Adv. Drug Delivery Rev.28, 71–84 (1997).
   PubMed Web of Science ®Google Scholar
• Kwak HH , ShimWS, ChoiMKet al. Development of a sustained release recombinant human growth hormone formulation. J. Control. Release 137, 160–165 (2009).
   PubMed Web of Science ®Google Scholar
• Castellanos IJ , FloresG, GriebenowK. Effect of cyclodextrins on α-chymotrypsin stability and loading in PLGA microspheres upon s/o/w emulsion. J. Pharm. Sci.95(4) 849–858 (2006).
   PubMed Web of Science ®Google Scholar
• Quaglia F , De Rosa G, Granata E et al. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray drying. J. Control. Release86, 267–278 (2003).
   PubMed Web of Science ®Google Scholar
• De Rosa G , LarobinaD, La Rotonda MI et al. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-β-cyclodextrin. J. Control. Release102, 71–83 (2005).
   PubMed Web of Science ®Google Scholar
• Bezemer JM , RadersmaR, GrijpmaDWet al. Zero-order release of lysozyme from poly(ethylene glycol)/poly(butylenes terephthalate matrices. J. Control. Release 64, 179–192 (2000).
   PubMed Web of Science ®Google Scholar
• Bezemer JM , RadersmaR, GrijpmaDW, DijkstraPJ, van Blitterswijk CA, Feijen J. Microspheres for protein delivery prepared from amphiphilic multibock copolymers 1 influence of preparation techniques on particle characteristics and protein delivery. J. Control. Release67, 233–248 (2000).
   PubMed Web of Science ®Google Scholar
• Van Dijkhuizen-Radersma R , NicolasHM, van de Weert M et al.Stability aspects of salmon calcitonin entrapped in poly(ether ester) sustained release systems, Int. J. Pharm.248, 229–237 (2002).
   PubMedGoogle Scholar
• Griebenow K , KilbanovAM. On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J. Am. Chem. Soc.118(47), 11695–11700 (1996).
   Web of Science ®Google Scholar
• Carrasquillo KG , StableyAM, Aponte-CarroJCet al. Non-aqueous encapsulation of excipient-stabilised spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control. Release 76, 199–208 (2001).
   PubMed Web of Science ®Google Scholar
• Petit DK , LawterJR, HuangWJet al.Characterisation of poly(glycolide-co-d,l-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF. Pharm. Res.14(10), 1422–1430 (1997).
   PubMed Web of Science ®Google Scholar
• Constantino HR , JohnsonOL, ZaleSE. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J. Pharm Sci.93(10), 2624–2634 (2004).
   PubMed Web of Science ®Google Scholar
• Takada S , YamagataY, MisakiM, TairaK, KurokawaT. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. J. Control. Release88, 229–242 (2003).
   PubMed Web of Science ®Google Scholar
• Castellanos IJ , CarrasquilloKG, LopezJDJ, AlvarezM, GriebenowK. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. J. Pharm. Pharmacol.53, 167–178 (2001).
   PubMed Web of Science ®Google Scholar
• Wang J , ChuaKM, WangCH. Stabilisation and encapsulation of human immunoglobulin G into biodegradable microspheres. J. Col. Inter. Sci.271, 92–101 (2004).
   PubMed Web of Science ®Google Scholar
• Kim TK , BurgessDJ. Pharmacokinetic characterisation of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J. Pharm. Pharmacol.54, 897–905 (2002).
   PubMed Web of Science ®Google Scholar
• Zhu G , MallerySR, SchwendemanSP. Stabilisation of proteins encapsulated in injectable poly(lactide-co-glycolide). Nature Biotech.18, 52–57 (2000).
   PubMed Web of Science ®Google Scholar
• Kang J , SchwendemanSP. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants. Biomaterials23, 239–245 (2002).
   PubMed Web of Science ®Google Scholar
• Castellanos IJ , CrespoR, GriebenowK. Poly(ethylene glycol) as stabiliser and emulsifying agent: a novel stabilisation approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J. Control. Release88, 135–145 (2003).
   PubMed Web of Science ®Google Scholar
• Castellanos IJ , GriebenowK. Improved α-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement. Pharm. Res.20(11), 1873–1880 (2003).
   PubMed Web of Science ®Google Scholar
• Morita T , SakamuraY, HorikiriY, SuzukiT, YoshinoH. Protein encapsulation into biodegradable microspheres by a novel s/o/w emulsion method using poly(ethylene glycol) as a protein micronisation adjuvant. J. Control. Release69, 435–444 (2000).
   PubMed Web of Science ®Google Scholar
• Morita T , HorikiriY, SuzukiT, YoshinoH. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres. Eu. J. Pharm. Biopharm.51, 45–53 (2001).
   PubMed Web of Science ®Google Scholar
• Takada S , YamagataY, MisakiM, TairaK, KurokawaT. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. J. Control. Release88, 229–242 (2003).
   PubMedGoogle Scholar
• Takada S , KurokawaT, MisakiM, TairaK, YamagataY. A new animal model for the evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations. J. Pharm. Pharmacol.55, 951–961 (2003).
   PubMed Web of Science ®Google Scholar
• Takenaga M , YamaguchiY, KitagawaA, OgawaY, MizushimaY, IgarashiR. A novel sustained release formulation of insulin with dramatic reduction in rapid release. J. Control. Release79, 81–91 (2002).
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y , TakenagaM, KitagawaA, OgawaY, MizushimaY, IgarashiR. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. J. Control. Release81, 235–249 (2002).
   PubMed Web of Science ®Google Scholar
• Takenaga M , YamaguchiY, KitagawaAet al. Optimum formulation for sustained release insulin. Int. J. Pharm. 271, 85–94 (2004).
   PubMed Web of Science ®Google Scholar
• Takenaga M , YamaguchiY, KitagawaA, OgawaY, MizushimaY, IgarashiR. A novel insulin formulation can keep providing steady levels of insulin for much longer periods in vivo. J. Pharm. Pharmacol.54, 1189–1194 (2002).
   PubMed Web of Science ®Google Scholar
• Tracy MA . Development and scale-up of a microsphere protein delivery system. Biotechnol. Prog.14, 108–115 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson OL , ClelandJL, LeeHJet al. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 2, 795–799 (1996).
   PubMed Web of Science ®Google Scholar
• Johnson OL , JaworowiczW, ClelandJLet al. The stabilisation and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14(6), 730–735 (1997).
   PubMed Web of Science ®Google Scholar
• Lee HJ , RileyG, JohnsonOet al. In vivo characterisation of sustained release formulations of human growth hormone. J. Pharmacol. Exp. Thera.281(3), 1431–1439 (1997).
   PubMed Web of Science ®Google Scholar
• Reiter EO , AttieKM, MoshangTet al. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency. J. Clin. Endo. Met. 86(10), 4700–4706 (2001).
   PubMed Web of Science ®Google Scholar
• Kemp SF , FielderPJ, AttieKMet al. Pharmacokinetic and pharmacodynamic characteristics of a long acting growth hormone (GH) preparation (Nutropin® Depot) in GH-deficient children. J. Clin. Endo. Met. 89(7), 3234–3240 (2004).
   PubMed Web of Science ®Google Scholar
• Howdle SM , WatsonMS, WhitakerMJet al. Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials. Chem. Commun. 2001, 109–110 (2001).
   Google Scholar
• Watson MS , WhitakerMJ, HowdleSM, ShakesheffKM. Incorporation of proteins into polymer materials by a novel supercritical fluid processing method. Adv. Mater.14(24), 1802–1804 (2002).
   Web of Science ®Google Scholar
• Hao J , WhitakerMJ, WongB, SerhatkuluG, ShakesheffKM, HowdleSM. Plasticization and spraying of poly(D,L-lactic acid) using supercritical carbon dioxide: control of particle size. J. Pharm. Sci.93(4), 1083–1090 (2004).
   PubMed Web of Science ®Google Scholar
• Hao J , WhitakerMJ, WongB, SerhatkuluG, ShakesheffKM, HowdleSM. Supercritical fluid assisted melting of poly(ethylene glycol): a new solvent-free route to microparticles. J. Mater. Chem.15, 1148–1153 (2005).
   Web of Science ®Google Scholar
• Whitaker MJ , HaoJ, DaviesORet al. The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. J. Control. Release 101, 85–92 (2005).
   PubMed Web of Science ®Google Scholar
• Jordan F , NaylorA, KellyCA, HowdleSM, LewisA, IllumL. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies. J. Control. Release141, 153–160 (2010).
   PubMed Web of Science ®Google Scholar
• Reslow M , JonssonM, LaaksoT. Sustained release of human growth hormone from PLG-coated starch microspheres. Drug Del. Sys. Sci.2, 103–109 (2002).
   Google Scholar
• Jostel A , MukherjeeA, AlenfallJ, SmethurstL, ShaletAM. A new sustained release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile. Clin. Endo.62, 623–627 (2005).
   PubMed Web of Science ®Google Scholar
• Stenekes RJH , FranssenO, van Brommel EMG, Crommelin DJA, Hennink WE. The preparation of dextran microspheres in an all-aqueous system: effect of formulation parameters on particle characteristics. Pharm. Res.15(4), 557–561 (1998).
   PubMed Web of Science ®Google Scholar
• Franssen O , VandervennetL, RodersP, HenninkWE. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J. Control. Release60, 211–221 (1999).
   PubMed Web of Science ®Google Scholar
• Vlugt-Wensink KDF , MeijerYJ, van Steenbergen MJ et al.Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres. Eur. J. Pharm. Biopharm.67, 589–596 (2007).
   PubMed Web of Science ®Google Scholar
• Vlugt-Wensink KDF , de Vreuh R, Gresnigt MG et al. Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation. Pharm. Res.24(12), 2239–2248 (2007).
   PubMed Web of Science ®Google Scholar
• Moore WV , LeppertP. Role of aggregated human growth hormone (hGH) in development of antibodies to hGH. J. Clin. Endo. Met.51(4), 691–697 (1980).
   PubMed Web of Science ®Google Scholar
• Woo BH , JiangG, JoYW, DeLucaPP. Preparation and characterisation of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm. Res.18(11), 1600–1606 (2001).
   PubMed Web of Science ®Google Scholar
• Capan Y , JiangG, GiovagnoliS, NaKH, DeLucaPP. Preparation and characterisation of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS PharmSciTech4(2) 1–10 (2003).
   Google Scholar
• Jiang G , QiuW, DeLucaPP. Preparation and in vitro-in vivo evaluation of insulin loaded poly(acryloyl hydroxyethyl starch)-PLGA composite microspheres. Pharm. Res.20(3), 452–459 (2003).
   PubMed Web of Science ®Google Scholar
• Schoubben A , BlasiP, GiovagnoliS, PerioliL, RossiC, RicciM. Novel composite microparticles for protein stabilisation and delivery. Eur. J. Pharm. Sci.36, 226–234 (2009).
   PubMed Web of Science ®Google Scholar
• Johansen P , TamberH, MerkleP, GanderB. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alhylated PLA/PLGAs. Eu. J. Pharm. Biopharm.47, 193–201 (1999).
   PubMed Web of Science ®Google Scholar
• Agrawal CM , AthanasiouKA. Technique to control pH in vicinity of biodegrading PLA-PLGA implants. J. Biomed. Mater. Res.38, 105–114 (1997).
   PubMed Web of Science ®Google Scholar
• Shao PG , BaileyLC. Stabilisation of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. Pharm. Dev. Technol.4, 633–642 (1999).
   PubMed Web of Science ®Google Scholar
• Kim HK , ParkTG. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. J. Control. Release98, 115–125 (2004).
   PubMed Web of Science ®Google Scholar
• Kim HK , ChungHJ, ParkTG. Biodegradable polymeric microspheres with open/closed pores for sustained release of human growth hormone. J. Control. Release112, 167–174 (2006).
   PubMed Web of Science ®Google Scholar
• Bae SE , SonJS, ParkK, HanDK. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J. Control. Release133, 37–43 (2009).
   PubMed Web of Science ®Google Scholar
• Lucke A , KiermaierJ, GopferichA. Peptide acylation by poly(α-hydroxy esters). Pharm. Res.19(2), 175–181 (2002).
   PubMed Web of Science ®Google Scholar
• Murty SB , GoodmanJ, ThanooBC, DeLucaPP. Identification of chemically modified peptide from poly(lactide-co-glycolide) microspheres under in vitro release conditions. AAPS PharmSciTech4(4), E50 (2003).
   PubMedGoogle Scholar
• Murty SB , ThanooBC, WeiQ, DeLucaPP Impurity formation studies with peptide loaded polymeric microspheres Part I. In vivo evaluation. Int. J. Pharm.297, 50–61 (2005).
   PubMed Web of Science ®Google Scholar
• Murty SB , DongHN, ThanooBC, DeLucaPP. Impurity formation studies with peptide loaded polymeric microspheres Part II. In vitro evaluation. Int. J. Pharm.297, 62–72 (2005).
   PubMed Web of Science ®Google Scholar
• Ibrahim MA , IsmailA, FetouchMI, GopferichA. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J. Control. Release106, 241–252 (2005).
   PubMed Web of Science ®Google Scholar
• Lam XM , DuenasET, ClelandJL. Encapsulation and stabilisation of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J. Pharm. Sci.90(9), 1356–1365 (2001).
   PubMed Web of Science ®Google Scholar
• Tsai T , MehtaRC, DeLucaPP. Adsorption of peptides to poly(D,L-lactide-co-glycolide):1 effect of physical factors. Int. J. Pharm.127, 31–42 (1996).
   Web of Science ®Google Scholar
• Tsai T , MehtaRC, DeLucaPP. Adsorption of peptides to poly(D,L-lactide-co-glycolide):2 effect of solution properties on the adsorption. Int. J. Pharm.127, 43–52 (1996).
   Web of Science ®Google Scholar
• Calis S , JeyanthiR, TsaiT, MehtaRC, DeLucaPP. Adsorption of salmon calcitonin to PLGA microspheres. Pharm. Res.12(7), 1072–1076 (1995).
   PubMed Web of Science ®Google Scholar
• Mehta RC , JeyanthiR, CalisS, ThanooBC, BurtonKW, DeLucaPP. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. J. Control. Release29, 375–384 (1994).
   Web of Science ®Google Scholar
• Jiang G , WooBH, KangF, SinghJ, DeLucaPP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. J. Control. Release79, 137–145 (2002).
   PubMed Web of Science ®Google Scholar
• Jiang W , SchwendemanSP. Stabilisation and controlled release of bovine serum albumin encapsulated in poly(D,L lactide) and poly(ethylene glycol) microsphere blends. Pharm. Res.18(6), 878–885 (2001).
   PubMed Web of Science ®Google Scholar
• Diaz RV , SorianoI, DelgadoA, LlabresM, EvoraC. Effect of surfactant agents on the release of 125I-bovine calcitonin from PLGA microspheres: in vitro–in vivo study. J. Control. Release43, 59–64 (1997).
   Web of Science ®Google Scholar
• De Rosa G , IommelliR, La Rotonda MI, Miro A, Quaglia F. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J. Control. Release69, 283–295 (2000).
   PubMed Web of Science ®Google Scholar
• Chan YP , MeyrueixR, KravtzoffR, NicolasF, LundstromK. Review on Medusa®: a polymer-based sustained release technology for protein and peptide drugs. Expert Opin. Drug Del.4(4), 441–451 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• Eligard prescribing information http://products.sanofi-aventis.us/eligard/eligard_75.html
   Google Scholar
• OctoPlus press release, June 2009 http://observer.OctoPlus.nl/index.cfm/OctoPlus/news-centre/news-releases/index.cfm?news-article=OctoPlus-licensee-biolex-completes-patient-enrollment-in-phase-iib-study-with-locteron
   Google Scholar
• Genentech press release, 1 June 2004 www.gene.com/gene/news/press-releases/display.do?method=detail&id=7447
   Google Scholar
• Flamel Technologies press release, 18 December 2009 www.flamel.com/pressReleases/2009.shtml
   Google Scholar